(provided by candidate): Systemic Lupus Erythematosus (SLE) is an autoimmune disease of uncertain etiology that is influenced not only by genetic but also by environmental factors. Particularly the latter remain poorly understood. Development of nephritis is a prominent feature in SLE, contributing substantially to morbidity and mortality. Present treatment options for nephritis are limited and associated with significant toxicity. Better understanding of the pathogenesis of renal disease in SLE may lead to the development of new, less toxic therapies. Pristane injected intraperitoneally (i.p.) into mice genetically not prone to autoimmune disease induces the production of lupus specific autoantibodies, including anti-DNA/chromatin, and immune complex nephritis. In preliminary studies we have found that IFNg and IL-6 are essential for both the production of these antibodies and the nephritis, but that nephritis may develop prior to the antibody response. We hypothesize that anti-DNA/chromatin autoantibodies are a marker for overproduction of inflammatory cytokines which promote nephritis, rather than the cause of renal disease in pristane-induced lupus. We propose to examine the temporal relationship between the production of autoantibodies and the development of nephritis in pristane-treated mice. Outcome of this study will answer whether anti-DNA/chromatin antibodies are obligatory for the development of nephritis or whether other factors are involved in development of renal disease. In an effort to determine if dysregulated cytokine homeostasis is sufficient to induce the production of autoantibodies and nephritis we plan to induce their constitutive expression by bone marrow derived cells. The proposed experiments will involve the transduction of hematopoietic stem cells with retroviral vectors encoding IFNg, IL-6 or both for later injection into mice. We predict that with this approach we will be able to induce autoantibody production and nephritis. Finally we aim to define the roles of ITAM vs ITIM containing Fc receptors for the development of nepliritis.We will initially study of the effect of FcgRI/III and FcgRII deficiency on pristane-induced lupus. Subsequently anti-DNA/chromatin antibody production and nephritis after pristane-treatment in FcgRI/III deficient mice over expressing IFNg or IL-6 and FcgRII deficient mice also deficient in IFNg or IL-6 will be studied. The out come of these experiments will determine if Fc receptor mediation is obligatory for the development of nephritis or whether a direct effect of cytokines alone is sufficient for the induction of renal disease. Based on our preliminary data we expect that Fc receptor signaling is the critical varialble for the induction of renal disease.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Clinical Investigator Award (CIA) (K08)
Project #
5K08DK002890-04
Application #
6784602
Study Section
Diabetes, Endocrinology and Metabolic Diseases B Subcommittee (DDK)
Program Officer
Rankin, Tracy L
Project Start
2001-09-01
Project End
2006-08-31
Budget Start
2004-09-01
Budget End
2005-08-31
Support Year
4
Fiscal Year
2004
Total Cost
$123,228
Indirect Cost
Name
University of Florida
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
969663814
City
Gainesville
State
FL
Country
United States
Zip Code
32611
Li, Yi; Lee, Pui Y; Sobel, Eric S et al. (2009) Increased expression of FcgammaRI/CD64 on circulating monocytes parallels ongoing inflammation and nephritis in lupus. Arthritis Res Ther 11:R6
Li, Yi; Tucci, Marco; Narain, Sonali et al. (2006) Urinary biomarkers in lupus nephritis. Autoimmun Rev 5:383-8
Clynes, Raphael; Calvani, Nicola; Croker, Byron P et al. (2005) Modulation of the immune response in pristane-induced lupus by expression of activation and inhibitory Fc receptors. Clin Exp Immunol 141:230-7
Barnes, E V; Narain, S; Naranjo, A et al. (2005) High sensitivity C-reactive protein in systemic lupus erythematosus: relation to disease activity, clinical presentation and implications for cardiovascular risk. Lupus 14:576-82
Calvani, Nicola; Caricchio, Roberto; Tucci, Marco et al. (2005) Induction of apoptosis by the hydrocarbon oil pristane: implications for pristane-induced lupus. J Immunol 175:4777-82
Calvani, N; Richards, H B; Tucci, M et al. (2004) Up-regulation of IL-18 and predominance of a Th1 immune response is a hallmark of lupus nephritis. Clin Exp Immunol 138:171-8
Tucci, Marco; Barnes, Elena V; Sobel, Eric S et al. (2004) Strong association of a functional polymorphism in the monocyte chemoattractant protein 1 promoter gene with lupus nephritis. Arthritis Rheum 50:1842-9
Calvani, Nicola; Satoh, Minoru; Croker, Byron P et al. (2003) Nephritogenic autoantibodies but absence of nephritis in Il-12p35-deficient mice with pristane-induced lupus. Kidney Int 64:897-905